Global and China Biologics and Biosimilars Market Insights, Forecast to 2027

Global and China Biologics and Biosimilars Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Biologics and Biosimilars Product Introduction
1.2 Market by Type
1.2.1 Global Biologics and Biosimilars Market Size Growth Rate by Type
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Others
1.3 Market by Application
1.3.1 Global Biologics and Biosimilars Market Size Growth Rate by Application
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biologics and Biosimilars Market Size, Estimates and Forecasts
2.1.1 Global Biologics and Biosimilars Revenue 2016-2027
2.1.2 Global Biologics and Biosimilars Sales 2016-2027
2.2 Global Biologics and Biosimilars, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Biologics and Biosimilars Historical Market Size by Region (2016-2021)
2.3.1 Global Biologics and Biosimilars Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Biologics and Biosimilars Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Biologics and Biosimilars Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Biologics and Biosimilars Sales Forecast by Region (2022-2027)
2.4.2 Global Biologics and Biosimilars Revenue Forecast by Region (2022-2027)
3 Global Biologics and Biosimilars Competitor Landscape by Players
3.1 Global Top Biologics and Biosimilars Manufacturers by Sales
3.1.1 Global Biologics and Biosimilars Sales by Manufacturer (2016-2021)
3.1.2 Global Biologics and Biosimilars Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Biologics and Biosimilars Manufacturers by Revenue
3.2.1 Key Biologics and Biosimilars Manufacturers Covered: Ranking by Revenue
3.2.2 Global Biologics and Biosimilars Revenue by Manufacturers (2016-2021)
3.2.3 Global Biologics and Biosimilars Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Biologics and Biosimilars Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Biologics and Biosimilars Revenue in 2020
3.2.6 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Biologics and Biosimilars Price by Manufacturers
3.4 Global Biologics and Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Biologics and Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologics and Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into Biologics and Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Biologics and Biosimilars Market Size by Type (2016-2021)
4.1.1 Global Biologics and Biosimilars Sales by Type (2016-2021)
4.1.2 Global Biologics and Biosimilars Revenue by Type (2016-2021)
4.1.3 Biologics and Biosimilars Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Biologics and Biosimilars Market Size Forecast by Type (2022-2027)
4.2.1 Global Biologics and Biosimilars Sales Forecast by Type (2022-2027)
4.2.2 Global Biologics and Biosimilars Revenue Forecast by Type (2022-2027)
4.2.3 Biologics and Biosimilars Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Biologics and Biosimilars Market Size by Application (2016-2021)
5.1.1 Global Biologics and Biosimilars Sales by Application (2016-2021)
5.1.2 Global Biologics and Biosimilars Revenue by Application (2016-2021)
5.1.3 Biologics and Biosimilars Price by Application (2016-2021)
5.2 Biologics and Biosimilars Market Size Forecast by Application (2022-2027)
5.2.1 Global Biologics and Biosimilars Sales Forecast by Application (2022-2027)
5.2.2 Global Biologics and Biosimilars Revenue Forecast by Application (2022-2027)
5.2.3 Global Biologics and Biosimilars Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Biologics and Biosimilars Market Size YoY Growth 2016-2027
6.1.1 China Biologics and Biosimilars Sales YoY Growth 2016-2027
6.1.2 China Biologics and Biosimilars Revenue YoY Growth 2016-2027
6.1.3 China Biologics and Biosimilars Market Share in Global Market 2016-2027
6.2 China Biologics and Biosimilars Market Size by Players (International and Local Players)
6.2.1 China Top Biologics and Biosimilars Players by Sales (2016-2021)
6.2.2 China Top Biologics and Biosimilars Players by Revenue (2016-2021)
6.3 China Biologics and Biosimilars Historic Market Review by Type (2016-2021)
6.3.1 China Biologics and Biosimilars Sales Market Share by Type (2016-2021)
6.3.2 China Biologics and Biosimilars Revenue Market Share by Type (2016-2021)
6.3.3 China Biologics and Biosimilars Price by Type (2016-2021)
6.4 China Biologics and Biosimilars Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Biologics and Biosimilars Sales Forecast by Type (2022-2027)
6.4.2 China Biologics and Biosimilars Revenue Forecast by Type (2022-2027)
6.4.3 China Biologics and Biosimilars Price Forecast by Type (2022-2027)
6.5 China Biologics and Biosimilars Historic Market Review by Application (2016-2021)
6.5.1 China Biologics and Biosimilars Sales Market Share by Application (2016-2021)
6.5.2 China Biologics and Biosimilars Revenue Market Share by Application (2016-2021)
6.5.3 China Biologics and Biosimilars Price by Application (2016-2021)
6.6 China Biologics and Biosimilars Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Biologics and Biosimilars Sales Forecast by Application (2022-2027)
6.6.2 China Biologics and Biosimilars Revenue Forecast by Application (2022-2027)
6.6.3 China Biologics and Biosimilars Price Forecast by Application (2022-2027)
7 North America
7.1 North America Biologics and Biosimilars Market Size YoY Growth 2016-2027
7.2 North America Biologics and Biosimilars Market Facts & Figures by Country
7.2.1 North America Biologics and Biosimilars Sales by Country (2016-2021)
7.2.2 North America Biologics and Biosimilars Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Biologics and Biosimilars Market Size YoY Growth 2016-2027
8.2 Asia Pacific Biologics and Biosimilars Market Facts & Figures by Region
8.2.1 Asia Pacific Biologics and Biosimilars Sales by Region (2016-2021)
8.2.2 Asia Pacific Biologics and Biosimilars Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Biologics and Biosimilars Market Size YoY Growth 2016-2027
9.2 Europe Biologics and Biosimilars Market Facts & Figures by Country
9.2.1 Europe Biologics and Biosimilars Sales by Country (2016-2021)
9.2.2 Europe Biologics and Biosimilars Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Biologics and Biosimilars Market Size YoY Growth 2016-2027
10.2 Latin America Biologics and Biosimilars Market Facts & Figures by Country
10.2.1 Latin America Biologics and Biosimilars Sales by Country (2016-2021)
10.2.2 Latin America Biologics and Biosimilars Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Biologics and Biosimilars Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Biologics and Biosimilars Market Facts & Figures by Country
11.2.1 Middle East and Africa Biologics and Biosimilars Sales by Country (2016-2021)
11.2.2 Middle East and Africa Biologics and Biosimilars Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Biologics and Biosimilars Products Offered
12.1.5 Roche Recent Development
12.2 Amgen
12.2.1 Amgen Corporation Information
12.2.2 Amgen Description and Business Overview
12.2.3 Amgen Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Amgen Biologics and Biosimilars Products Offered
12.2.5 Amgen Recent Development
12.3 AbbVie
12.3.1 AbbVie Corporation Information
12.3.2 AbbVie Description and Business Overview
12.3.3 AbbVie Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.3.4 AbbVie Biologics and Biosimilars Products Offered
12.3.5 AbbVie Recent Development
12.4 Sanofi-Aventis
12.4.1 Sanofi-Aventis Corporation Information
12.4.2 Sanofi-Aventis Description and Business Overview
12.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi-Aventis Biologics and Biosimilars Products Offered
12.4.5 Sanofi-Aventis Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Description and Business Overview
12.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Johnson & Johnson Biologics and Biosimilars Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Description and Business Overview
12.6.3 Pfizer Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Biologics and Biosimilars Products Offered
12.6.5 Pfizer Recent Development
12.7 Novo Nordisk
12.7.1 Novo Nordisk Corporation Information
12.7.2 Novo Nordisk Description and Business Overview
12.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Novo Nordisk Biologics and Biosimilars Products Offered
12.7.5 Novo Nordisk Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Description and Business Overview
12.8.3 Eli Lilly Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Eli Lilly Biologics and Biosimilars Products Offered
12.8.5 Eli Lilly Recent Development
12.9 Novartis
12.9.1 Novartis Corporation Information
12.9.2 Novartis Description and Business Overview
12.9.3 Novartis Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Novartis Biologics and Biosimilars Products Offered
12.9.5 Novartis Recent Development
12.10 Merck
12.10.1 Merck Corporation Information
12.10.2 Merck Description and Business Overview
12.10.3 Merck Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Merck Biologics and Biosimilars Products Offered
12.10.5 Merck Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Biologics and Biosimilars Products Offered
12.11.5 Roche Recent Development
12.12 Changchun High Tech
12.12.1 Changchun High Tech Corporation Information
12.12.2 Changchun High Tech Description and Business Overview
12.12.3 Changchun High Tech Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Changchun High Tech Products Offered
12.12.5 Changchun High Tech Recent Development
12.13 CP Guojian
12.13.1 CP Guojian Corporation Information
12.13.2 CP Guojian Description and Business Overview
12.13.3 CP Guojian Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.13.4 CP Guojian Products Offered
12.13.5 CP Guojian Recent Development
12.14 Biotech
12.14.1 Biotech Corporation Information
12.14.2 Biotech Description and Business Overview
12.14.3 Biotech Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Biotech Products Offered
12.14.5 Biotech Recent Development
12.15 Gelgen
12.15.1 Gelgen Corporation Information
12.15.2 Gelgen Description and Business Overview
12.15.3 Gelgen Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Gelgen Products Offered
12.15.5 Gelgen Recent Development
12.16 Innovent
12.16.1 Innovent Corporation Information
12.16.2 Innovent Description and Business Overview
12.16.3 Innovent Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Innovent Products Offered
12.16.5 Innovent Recent Development
12.17 Dong Bao
12.17.1 Dong Bao Corporation Information
12.17.2 Dong Bao Description and Business Overview
12.17.3 Dong Bao Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Dong Bao Products Offered
12.17.5 Dong Bao Recent Development
12.18 Ganlee
12.18.1 Ganlee Corporation Information
12.18.2 Ganlee Description and Business Overview
12.18.3 Ganlee Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Ganlee Products Offered
12.18.5 Ganlee Recent Development
12.19 United Laboratories
12.19.1 United Laboratories Corporation Information
12.19.2 United Laboratories Description and Business Overview
12.19.3 United Laboratories Biologics and Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.19.4 United Laboratories Products Offered
12.19.5 United Laboratories Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Biologics and Biosimilars Industry Trends
13.2 Biologics and Biosimilars Market Drivers
13.3 Biologics and Biosimilars Market Challenges
13.4 Biologics and Biosimilars Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologics and Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Biologics and Biosimilars Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Interferon
Table 4. Major Manufacturers of Erythropoietin
Table 5. Major Manufacturers of Insulin
Table 6. Major Manufacturers of Vaccines
Table 7. Major Manufacturers of Others
Table 8. Global Biologics and Biosimilars Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 9. Global Biologics and Biosimilars Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Biologics and Biosimilars Sales by Regions (2016-2021) & (K Units)
Table 11. Global Biologics and Biosimilars Sales Market Share by Regions (2016-2021)
Table 12. Global Biologics and Biosimilars Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Biologics and Biosimilars Sales Forecast by Region (2022-2027) & (K Units)
Table 14. Global Biologics and Biosimilars Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Biologics and Biosimilars Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Biologics and Biosimilars Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Biologics and Biosimilars Sales by Manufacturers (2016-2021) (K Units)
Table 18. Global Biologics and Biosimilars Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Biologics and Biosimilars Manufacturers by Revenue (US$ Million) in 2020
Table 20. Biologics and Biosimilars Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Biologics and Biosimilars Revenue Share by Manufacturers (2016-2021)
Table 22. Global Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Biologics and Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics and Biosimilars as of 2020)
Table 24. Key Manufacturers Biologics and Biosimilars Price (2016-2021) (USD/Unit)
Table 25. Biologics and Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Biologics and Biosimilars Product Type
Table 27. Date of International Manufacturers Enter into Biologics and Biosimilars Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Biologics and Biosimilars Sales by Type (2016-2021) (K Units)
Table 30. Global Biologics and Biosimilars Sales Share by Type (2016-2021)
Table 31. Global Biologics and Biosimilars Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Biologics and Biosimilars Revenue Share by Type (2016-2021)
Table 33. Biologics and Biosimilars Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 34. Global Biologics and Biosimilars Sales Forecast by Type (2022-2027) & (K Units)
Table 35. Global Biologics and Biosimilars Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Biologics and Biosimilars Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Biologics and Biosimilars Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Biologics and Biosimilars Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 39. Global Biologics and Biosimilars Sales by Application (2016-2021) (K Units)
Table 40. Global Biologics and Biosimilars Sales Share by Application (2016-2021)
Table 41. Global Biologics and Biosimilars Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Biologics and Biosimilars Revenue Share by Application (2016-2021)
Table 43. Biologics and Biosimilars Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 44. Global Biologics and Biosimilars Sales Forecast by Application (2022-2027) & (K Units)
Table 45. Global Biologics and Biosimilars Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Biologics and Biosimilars Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Biologics and Biosimilars Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Biologics and Biosimilars Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 49. China Biologics and Biosimilars Sales (K Units) of Key Companies (2016-2021)
Table 50. China Biologics and Biosimilars Sales Share by Company (2016-2021)
Table 51. China Biologics and Biosimilars Revenue (US$ Million) by Company (2016-2021)
Table 52. China Biologics and Biosimilars Revenue Share by Company (2016-2021)
Table 53. China Biologics and Biosimilars Sales (K Units) by Type (2016-2021)
Table 54. China Biologics and Biosimilars Sales Share by Type (2016-2021)
Table 55. China Biologics and Biosimilars Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. China Biologics and Biosimilars Price (USD/Unit) by Type (2016-2021)
Table 57. China Biologics and Biosimilars Sales (K Units) by Type (2022-2027)
Table 58. China Biologics and Biosimilars Sales Share by Type (2022-2027)
Table 59. China Biologics and Biosimilars Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. China Biologics and Biosimilars Revenue Share by Type (2022-2027)
Table 61. China Biologics and Biosimilars Price (USD/Unit) by Type (2022-2027)
Table 62. China Biologics and Biosimilars Sales (K Units) by Application (2016-2021)
Table 63. China Biologics and Biosimilars Sales Share by Application (2016-2021)
Table 64. China Biologics and Biosimilars Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. China Biologics and Biosimilars Price (USD/Unit) by Application (2016-2021)
Table 66. China Biologics and Biosimilars Sales (K Units) by Application (2022-2027)
Table 67. China Biologics and Biosimilars Sales Share by Application (2022-2027)
Table 68. China Biologics and Biosimilars Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. China Biologics and Biosimilars Revenue Share by Application (2022-2027)
Table 70. China Biologics and Biosimilars Price (USD/Unit) by Application (2022-2027)
Table 71. North America Biologics and Biosimilars Sales by Country (2016-2021) & (K Units)
Table 72. North America Biologics and Biosimilars Sales Market Share by Country (2016-2021)
Table 73. North America Biologics and Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Biologics and Biosimilars Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Biologics and Biosimilars Sales by Region (2016-2021) & (K Units)
Table 76. Asia Pacific Biologics and Biosimilars Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Biologics and Biosimilars Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Biologics and Biosimilars Revenue Market Share by Region (2016-2021)
Table 79. Europe Biologics and Biosimilars Sales by Country (2016-2021) & (K Units)
Table 80. Europe Biologics and Biosimilars Sales Market Share by Country (2016-2021)
Table 81. Europe Biologics and Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Biologics and Biosimilars Revenue Market Share by Country (2016-2021)
Table 83. Latin America Biologics and Biosimilars Sales by Country (2016-2021) & (K Units)
Table 84. Latin America Biologics and Biosimilars Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Biologics and Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Biologics and Biosimilars Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Biologics and Biosimilars Sales by Country (2016-2021) & (K Units)
Table 88. Middle East and Africa Biologics and Biosimilars Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Biologics and Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Country (2016-2021)
Table 91. Roche Corporation Information
Table 92. Roche Description and Business Overview
Table 93. Roche Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 94. Roche Biologics and Biosimilars Product
Table 95. Roche Recent Development
Table 96. Amgen Corporation Information
Table 97. Amgen Description and Business Overview
Table 98. Amgen Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 99. Amgen Product
Table 100. Amgen Recent Development
Table 101. AbbVie Corporation Information
Table 102. AbbVie Description and Business Overview
Table 103. AbbVie Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 104. AbbVie Product
Table 105. AbbVie Recent Development
Table 106. Sanofi-Aventis Corporation Information
Table 107. Sanofi-Aventis Description and Business Overview
Table 108. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 109. Sanofi-Aventis Product
Table 110. Sanofi-Aventis Recent Development
Table 111. Johnson & Johnson Corporation Information
Table 112. Johnson & Johnson Description and Business Overview
Table 113. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 114. Johnson & Johnson Product
Table 115. Johnson & Johnson Recent Development
Table 116. Pfizer Corporation Information
Table 117. Pfizer Description and Business Overview
Table 118. Pfizer Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 119. Pfizer Product
Table 120. Pfizer Recent Development
Table 121. Novo Nordisk Corporation Information
Table 122. Novo Nordisk Description and Business Overview
Table 123. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 124. Novo Nordisk Product
Table 125. Novo Nordisk Recent Development
Table 126. Eli Lilly Corporation Information
Table 127. Eli Lilly Description and Business Overview
Table 128. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 129. Eli Lilly Product
Table 130. Eli Lilly Recent Development
Table 131. Novartis Corporation Information
Table 132. Novartis Description and Business Overview
Table 133. Novartis Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 134. Novartis Product
Table 135. Novartis Recent Development
Table 136. Merck Corporation Information
Table 137. Merck Description and Business Overview
Table 138. Merck Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 139. Merck Product
Table 140. Merck Recent Development
Table 141. 3sbio Corporation Information
Table 142. 3sbio Description and Business Overview
Table 143. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 144. 3sbio Product
Table 145. 3sbio Recent Development
Table 146. Changchun High Tech Corporation Information
Table 147. Changchun High Tech Description and Business Overview
Table 148. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 149. Changchun High Tech Product
Table 150. Changchun High Tech Recent Development
Table 151. CP Guojian Corporation Information
Table 152. CP Guojian Description and Business Overview
Table 153. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 154. CP Guojian Product
Table 155. CP Guojian Recent Development
Table 156. Biotech Corporation Information
Table 157. Biotech Description and Business Overview
Table 158. Biotech Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 159. Biotech Product
Table 160. Biotech Recent Development
Table 161. Gelgen Corporation Information
Table 162. Gelgen Description and Business Overview
Table 163. Gelgen Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 164. Gelgen Product
Table 165. Gelgen Recent Development
Table 166. Innovent Corporation Information
Table 167. Innovent Description and Business Overview
Table 168. Innovent Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 169. Innovent Product
Table 170. Innovent Recent Development
Table 171. Dong Bao Corporation Information
Table 172. Dong Bao Description and Business Overview
Table 173. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 174. Dong Bao Product
Table 175. Dong Bao Recent Development
Table 176. Ganlee Corporation Information
Table 177. Ganlee Description and Business Overview
Table 178. Ganlee Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 179. Ganlee Product
Table 180. Ganlee Recent Development
Table 181. United Laboratories Corporation Information
Table 182. United Laboratories Description and Business Overview
Table 183. United Laboratories Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 184. United Laboratories Product
Table 185. United Laboratories Recent Development
Table 186. Biologics and Biosimilars Market Trends
Table 187. Biologics and Biosimilars Market Drivers
Table 188. Biologics and Biosimilars Market Challenges
Table 189. Biologics and Biosimilars Market Restraints
Table 190. Biologics and Biosimilars Customers List
Table 191. Biologics and Biosimilars Distributors List
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics and Biosimilars Product Picture
Figure 2. Global Biologics and Biosimilars Sales Market Share by Type in 2020 & 2027
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Interferon Product Picture
Figure 5. Erythropoietin Product Picture
Figure 6. Insulin Product Picture
Figure 7. Vaccines Product Picture
Figure 8. Others Product Picture
Figure 9. Global Biologics and Biosimilars Sales Market Share by Application in 2020 & 2027
Figure 10. Tumor
Figure 11. Diabetes
Figure 12. Cardiovascular
Figure 13. Hemophilia
Figure 14. Others
Figure 15. Biologics and Biosimilars Report Years Considered
Figure 16. Global Biologics and Biosimilars Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Biologics and Biosimilars Market Size 2016-2027 (US$ Million)
Figure 18. Global Biologics and Biosimilars Sales 2016-2027 (K Units)
Figure 19. Global Biologics and Biosimilars Market Size Market Share by Region: 2021 Versus 2027
Figure 20. Global Biologics and Biosimilars Sales Market Share by Region (2016-2021)
Figure 21. Global Biologics and Biosimilars Sales Market Share by Region in 2020
Figure 22. Global Biologics and Biosimilars Revenue Market Share by Region (2016-2021)
Figure 23. Global Biologics and Biosimilars Revenue Market Share by Region in 2020
Figure 24. Global Biologics and Biosimilars Sales Share by Manufacturer in 2020
Figure 25. The Top 10 and 5 Players Market Share by Biologics and Biosimilars Revenue in 2020
Figure 26. Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 27. Global Biologics and Biosimilars Sales Market Share by Type (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs